3 Things Investors Will Love About Doximity (and 1 They Won't)
Doximity (NYSE: DOCS) was viewed as an exciting, fast-growing telehealth company when it went public in 2021. Since then, however, investors have cooled to the stock, and it is down 42%. But are investors making a mistake and overlooking a possible gem in the healthcare industry?
Here's a look at three reasons why Doximity makes for an attractive investment, as well as a potentially important reason to hold off on adding the stock to your portfolio right now.
One of the most important numbers for growth-oriented companies is the revenue retention rate, which tells you how much more (or less) customers are spending with a business compared to the previous year. It's also a good indicator of a company's ability to retain customers.
Source Fool.com
